Dr. Manal El-Sayed (Cairo, Egypt) is Professor of Pediatrics, Chair of the Pediatric department and director of the Clinical Research Center (MASRI-CRC) at the Faculty of Medicine, Ain Shams University. Dr El-Sayed is a founding member of the Egyptian National Committee for Control of Viral Hepatitis (NCCVH) since 2006. She contributed to the establishment of a nationwide network of more than 120 specialized liver centers providing antiviral therapy for more than 3.5 million HCV-infected patients. Manal collaborated on the development of the national action plan for prevention and control of viral hepatitis published in 2014 with representatives from WHO, U.S. CDC, Pasteur Institute, and national stakeholders. In addition to co-supervising the nationwide mass screening program for adults and clinical director of the school screening program reaching so far more than 62 million people. Manal is the secretary general of the Egyptian Liver Care Society, an NGO offering financial assistance to patients receiving hepatitis treatment or liver transplants as well as children with chronic viral hepatitis.

She authored and co-authored numerous journal articles on hepatitis, and participated in the development of the WHO’s global HBV, HCV and diagnostic guidelines. Between 2011-2015, Manal was Vice Chair of WHO’s technical advisory group for prevention and control of viral hepatitis in Egypt and is member of the Global Accelerator for Pediatric Formulations (GAP-f). She is governing board member of the International Coalition for Elimination of hepatitis B (ICE-HBV) since 2020 and among board of directors for the Hepatitis Fund (EndHep2030). In addition to co-organising and co-chairing numerous international meetings on viral hepatitis and liver disease in Europe, US and Africa. Professor El-Sayed co-founded and co-chairs the Conference on Liver Disease in Africa and is the President of the Society on Liver Disease in Africa (SOLDA). She received the Egyptian State Appreciation Award in advanced technological sciences that serve the fields of medical sciences in 2022.